Tower Research Capital (TRC)’s Antares Pharma, Inc. ATRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,285
Closed -$13K 7034
2022
Q1
$13K Sell
3,285
-566
-15% -$2.24K ﹤0.01% 4029
2021
Q4
$14K Sell
3,851
-29,844
-89% -$108K ﹤0.01% 4139
2021
Q3
$122K Buy
33,695
+27,972
+489% +$101K ﹤0.01% 2225
2021
Q2
$25K Sell
5,723
-12,982
-69% -$56.7K ﹤0.01% 3709
2021
Q1
$77K Sell
18,705
-5,975
-24% -$24.6K ﹤0.01% 2791
2020
Q4
$98K Sell
24,680
-162,131
-87% -$644K ﹤0.01% 2377
2020
Q3
$505K Buy
186,811
+151,672
+432% +$410K 0.01% 1677
2020
Q2
$97K Buy
+35,139
New +$97K ﹤0.01% 2488
2020
Q1
Sell
-100
Closed 4257
2019
Q4
$0 Sell
100
-1,109
-92% ﹤0.01% 4687
2019
Q3
$4K Buy
+1,209
New +$4K ﹤0.01% 3491
2019
Q1
Sell
-1,706
Closed -$5K 4521
2018
Q4
$5K Sell
1,706
-11,098
-87% -$32.5K ﹤0.01% 2966
2018
Q3
$43K Buy
+12,804
New +$43K ﹤0.01% 1857
2018
Q2
Sell
-832
Closed -$2K 4245
2018
Q1
$2K Sell
832
-3,584
-81% -$8.62K ﹤0.01% 2999
2017
Q4
$9K Sell
4,416
-13,578
-75% -$27.7K ﹤0.01% 2642
2017
Q3
$59K Buy
+17,994
New +$59K ﹤0.01% 1824
2017
Q2
Sell
-21,373
Closed -$60K 3813
2017
Q1
$60K Sell
21,373
-721
-3% -$2.02K 0.01% 664
2016
Q4
$51K Buy
22,094
+1,620
+8% +$3.74K 0.01% 1417
2016
Q3
$34K Buy
20,474
+12,147
+146% +$20.2K ﹤0.01% 1349
2016
Q2
$9K Buy
8,327
+8,139
+4,329% +$8.8K ﹤0.01% 2954
2016
Q1
$0 Sell
188
-24,126
-99% ﹤0.01% 5215
2015
Q4
$29K Buy
24,314
+18,607
+326% +$22.2K ﹤0.01% 925
2015
Q3
$10K Sell
5,707
-3,605
-39% -$6.32K ﹤0.01% 2329
2015
Q2
$20K Buy
9,312
+810
+10% +$1.74K ﹤0.01% 2113
2015
Q1
$23K Buy
8,502
+8,300
+4,109% +$22.5K ﹤0.01% 2151
2014
Q4
$1K Sell
202
-45,826
-100% -$227K ﹤0.01% 3777
2014
Q3
$84K Buy
+46,028
New +$84K 0.01% 1112
2013
Q4
Sell
-14,293
Closed -$58K 5052
2013
Q3
$58K Buy
+14,293
New +$58K 0.01% 1784